Did you know new #pcos diagnosis guidelines allow diagnosis without ultrasound using AMH blood level!?
From personal experience navigating PCOS diagnosis, I found the use of AMH blood levels truly empowering. Traditionally, ultrasounds were the primary diagnostic tool, but they can sometimes be inconclusive or inaccessible. The AMH hormone, produced by granulosa cells of antral follicles, correlates strongly with ovarian follicle count, which is typically elevated in PCOS cases. Having consulted specialists, I learned that AMH levels are often significantly higher in women with PCOS—sometimes reflecting over 25 follicles per ovary rather than the typical 12. This makes AMH measurement a valuable, minimally invasive frontline screening test. However, it’s essential to consider AMH alongside symptoms like irregular cycles, high androgen signs such as acne or excessive hair growth, and insulin resistance indicators. I also appreciated how using AMH levels can complement fertility planning and treatment options like IVF, by providing deeper insights into ovarian reserve and function without repeated imaging. While it doesn’t completely replace ultrasound for all cases, especially when anatomical detail is required, its growing acceptance in guidelines marks a positive shift towards simpler, patient-friendly approaches. If you suspect PCOS, discussing AMH testing with your doctor might offer more clarity and potentially streamline your diagnostic journey. Remember, elevated AMH alone isn’t definitive—symptom patterns and further labs remain crucial. But having an alternative to ultrasound opens new avenues for early detection and personalized care.












































































































